Complete Wegovy and Mounjaro Switching Guide
Why Switch Between Wegovy and Mounjaro: Dose Comparison Benefits
The decision to switch between Wegovy (semaglutide) and Mounjaro (tirzepatide) often centres on individual response, cost considerations, and practical factors. Wegovy targets GLP-1 receptors exclusively, while Mounjaro works as a dual GIP and GLP-1 receptor agonist, representing different approaches to appetite regulation. Many patients find switching beneficial when their current medication isn't delivering expected results or when cost becomes a significant factor. Understanding the wegovy and mounjaro dose comparison helps patients and prescribers make informed switching decisions based on equivalent therapeutic effects.
The switching process requires careful dose conversion because these medications use different strength measurements and escalation schedules. Wegovy follows a structured 20-week escalation from 0.25mg to 2.4mg maintenance, whilst Mounjaro typically escalates from 2.5mg to 15mg maximum dose. Your prescriber will determine appropriate conversion ratios based on your current dose, treatment response, and individual tolerance factors. At EverydayMeds, we support patients through this transition by maintaining stock of both medications, ensuring continuity of supply during the switching period.
Wegovy and Mounjaro Dose Comparison: Pricing and Value Analysis
Cost comparison reveals significant potential savings when switching from Mounjaro to Wegovy. Wegovy begins at £79.99 for the 0.25mg starter dose, escalating to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our bundle options provide additional convenience, with the Intro Trio (0.25mg, 0.5mg, 1mg) available for £299.99, covering the first 12 weeks of treatment. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices.
When considering a wegovy and mounjaro dose comparison for budgeting purposes, Wegovy's pricing structure often presents a more accessible long-term option. The Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99, offering supply security and reduced ordering frequency. Mounjaro's pricing typically exceeds these levels across equivalent therapeutic doses. This cost differential makes switching particularly attractive for patients seeking sustainable long-term weight management without compromising clinical effectiveness through our GPhC-registered service (#9012878).
Clinical Evidence Supporting Wegovy and Mounjaro Dose Comparison
Clinical trial data supports both medications' effectiveness in weight management, though direct head-to-head comparisons require careful interpretation due to different trial designs and populations. Wegovy demonstrated significant weight loss in the STEP trials, with patients losing approximately 15% of body weight at 68 weeks when combined with lifestyle modifications (Wilding et al., NEJM, 2021). The SELECT trial further showed a 20% reduction in major cardiovascular events, highlighting additional health benefits beyond weight management.
Mounjaro's SURMOUNT trials showed impressive results with its dual-mechanism approach, though comparing absolute percentages between trials isn't methodologically sound due to different study populations and endpoints. When conducting a wegovy and mounjaro dose comparison, your prescriber will consider your individual response patterns, medical history, and treatment goals rather than relying solely on population-level trial outcomes. Both medications require combination with reduced-calorie diet and increased physical activity for optimal effectiveness.
How Wegovy Works in Wegovy and Mounjaro Dose Comparison
Wegovy's mechanism centres on GLP-1 receptor agonism, mimicking the natural incretin hormone that regulates appetite and food intake. This prescription-only medicine binds to GLP-1 receptors in the brain's appetite control centres, promoting satiety after smaller meals and reducing food cravings between meals. The once-weekly injection provides sustained appetite suppression throughout the treatment period, supporting consistent dietary adherence. Unlike Mounjaro's dual-receptor approach, Wegovy's single-pathway mechanism offers predictable dose-response relationships that facilitate easier dose conversion calculations. This targeted action makes Wegovy particularly suitable for patients who respond well to GLP-1 stimulation but may experience side effects from additional receptor activation pathways.
Streamlined Ordering Process for Wegovy and Mounjaro Dose Comparison
EverydayMeds simplifies the switching process through our comprehensive clinical assessment system designed for both medications. The initial 3-minute online assessment captures your current medication history, dose level, and switching rationale for prescriber review. Our qualified prescribers evaluate your wegovy and mounjaro dose comparison needs within 3 working days (or 24 hours with express service), ensuring safe transition protocols are followed. Once approved, your new medication ships via next-day cold-chain delivery, maintaining the strict temperature control required for GLP-1 medications. This streamlined process eliminates supply gaps that could disrupt your weight management journey during the switching period.
Storage Advantages in Wegovy and Mounjaro Dose Comparison
Storage convenience represents a significant practical advantage for Wegovy in dose comparisons with Mounjaro. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability period provides greater flexibility for travel, work schedules, and daily routine management without compromising medication integrity. Both medications require refrigeration at 2-8°C before first use and utilise similar pen-injector technology for administration. The dose escalation schedules differ significantly, with Wegovy's 4-week intervals per dose level allowing more gradual adjustment compared to Mounjaro's typical escalation pattern, potentially reducing side effect intensity during the switching transition period.
Comprehensive Switching Strategy for Wegovy and Mounjaro Dose Comparison
Successful switching between these medications requires individualised conversion protocols that account for previous dose levels, treatment duration, and clinical response patterns. Patients switching from higher Mounjaro doses may start Wegovy at an intermediate level rather than the standard 0.25mg starting dose, though this decision rests entirely with your prescriber's clinical judgement. The wegovy and mounjaro dose comparison must consider half-life differences, receptor binding profiles, and individual pharmacokinetic variations that affect switching timing.
EverydayMeds supports complex switching scenarios through our clinical team's expertise in GLP-1 medications and dose conversion protocols. We maintain comprehensive stock levels of all Wegovy strengths, ensuring immediate availability regardless of your prescribed starting dose during the switch. Our bundle options can be customised to match your specific switching schedule, whether you need multiple starter doses for gradual conversion or immediate access to higher strengths based on your previous Mounjaro dose level.
Expert Wegovy and Mounjaro Dose Comparison: Final Considerations
The decision to switch medications should balance clinical effectiveness, cost considerations, and practical factors unique to your lifestyle and treatment goals. Both Wegovy and Mounjaro are available through EverydayMeds' GPhC-registered service (#9012878), ensuring continuity of care regardless of your medication choice. Your prescriber can provide personalised guidance on optimal switching timing, appropriate dose conversion ratios, and monitoring requirements during the transition period. Our clinical assessment process evaluates your complete treatment history to support informed switching decisions that maintain your weight management progress.
Remember to apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing structure. The combination of cost savings, storage convenience, and proven clinical effectiveness makes Wegovy an attractive option for many patients considering a switch. Complete your clinical assessment today to explore whether switching aligns with your treatment objectives and budget requirements through our expert clinical guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
